CERES INC. Logo

CERES INC.

Develops online media platforms connecting consumers with advertisers through a rewards system.

3696 | T

Overview

Corporate Details

ISIN(s):
JP3423570005
LEI:
Country:
Japan
Address:
渋谷区桜丘町1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ceres Inc. is an internet marketing company operating under the mission of "Enriching the world through internet marketing." The company's core business involves the development and management of online media platforms. Its flagship service is "Moppy," a point media site where users can accumulate points through various online activities and exchange them for rewards. By connecting a large consumer base with advertisers, Ceres provides marketing and user acquisition solutions for businesses while offering value to its platform users.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 05:30
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-08-13 05:29
Interim Report
半期報告書-第21期(2025/01/01-2025/12/31)
Japanese 228.9 KB
2025-07-18 08:49
M&A Activity
臨時報告書
Japanese 22.5 KB
2025-07-01 08:56
Major Shareholding Notification
大量保有報告書
Japanese 34.4 KB
2025-05-08 09:40
Regulatory News Service
臨時報告書
Japanese 19.1 KB
2025-04-21 09:17
Share Issue/Capital Change
臨時報告書
Japanese 30.8 KB
2025-03-26 06:24
Governance Information
内部統制報告書-第20期(2024/01/01-2024/12/31)
Japanese 23.2 KB
2025-03-26 06:18
Registration Form
確認書
Japanese 8.1 KB
2025-03-26 06:10
Annual Report
有価証券報告書-第20期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-03-26 05:15
Post-Annual General Meeting Information
臨時報告書
Japanese 24.6 KB
2025-02-14 09:14
Regulatory News Service
臨時報告書
Japanese 19.7 KB
2025-02-14 09:14
Regulatory News Service
臨時報告書
Japanese 18.0 KB
2025-01-27 09:12
Regulatory News Service
臨時報告書
Japanese 22.6 KB
2024-08-13 08:58
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-08-13 08:57
Interim Report
半期報告書-第20期(2024/01/01-2024/12/31)
Japanese 197.3 KB

Automate Your Workflow. Get a real-time feed of all CERES INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CERES INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CERES INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

QUINSTREET, INC Logo
AI-driven marketplaces connecting consumers to brands in finance & home services on a pay-per-result basis.
United States of America
QNST
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978

Talk to a Data Expert

Have a question? We'll get back to you promptly.